Precision Medicine in the Era of Genomics
The intersection of increasingly accessible genomic-based sequencing and technology platforms with expanding sources of patients’ digital health data has created an opportunity to drive adoption and impact of precision medicine. This panel, hosted at Datavant’s 2022 Future of Health Data Summit, examines the opportunities and challenges to transforming personalized patient care.
- Amy Abernethy, President, Clinical Research Platforms, Verily
- Lloyd Minor, Dean, Stanford University School of Medicine
- Andrea Ramirez, Chief Data Officer, NIH – All of Us
This panel was moderated by Gaurav Singal, Former Chief Data Officer, Foundation Medicine.